ResearcherRoswell Park Comprehensive Cancer CenterNo recent work listed
Katherine T. Ostapoff
Matched on OpenAlex author ID A5021634992. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2012: 1 paper · 2013: 2 papers · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper
Papers 7
- Ablative Therapies for Locally Advanced Pancreatic Cancer. First author DOI 10.1097/mpa.0000000000000948↗
- Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma? Co-author DOI 10.1016/j.hpb.2017.03.002↗
- Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model. First author DOI 10.18632/oncotarget.10514↗
- Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis. Co-author DOI 10.1158/0008-5472.can-13-1807↗
- BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer. First author DOI 10.1158/1535-7163.mct-12-0995↗
- PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic cancer. Co-author DOI 10.1158/1535-7163.mct-12-1123↗
- Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-12-0453↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rolf A. Brekken · 5 shared papers, 2012–2016 · strength 0.22
- Paper Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model. DOI 10.18632/oncotarget.10514↗
- Paper BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinic… DOI 10.1158/1535-7163.mct-12-0995↗
- Paper PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic… DOI 10.1158/1535-7163.mct-12-1123↗
- Boris W. Kuvshinoff · 2 shared papers, 2017–2018 · strength 0.20
- Steven N. Hochwald · 2 shared papers, 2017–2018 · strength 0.20
- Bercin Kutluk Cenik · 3 shared papers, 2013–2014 · strength 0.13
- Paper BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinic… DOI 10.1158/1535-7163.mct-12-0995↗
- Paper PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic… DOI 10.1158/1535-7163.mct-12-1123↗
- Paper Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis. DOI 10.1158/0008-5472.can-13-1807↗
- Rupen A. Shah · 1 shared paper, 2018 · strength 0.12
- Emmanuel M Gabriel · 1 shared paper, 2017 · strength 0.08
- Roderich Egbert Schwarz · 2 shared papers, 2012–2013 · strength 0.07
- Paper PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic… DOI 10.1158/1535-7163.mct-12-1123↗
- Paper Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pan… DOI 10.1158/1078-0432.ccr-12-0453↗
- Volkan N. Adsay · 1 shared paper, 2016 · strength 0.06
- Jack L. Arbiser · 1 shared paper, 2016 · strength 0.06
- Begoña Díaz · 1 shared paper, 2016 · strength 0.06
- Niranjan Awasthi · 1 shared paper, 2013 · strength 0.04
- Mary Topalovski · 1 shared paper, 2014 · strength 0.04
- Moriah M. Hagopian · 1 shared paper, 2014 · strength 0.04
- Francis J. Burrows · 1 shared paper, 2012 · strength 0.03
- Amanda Kirane · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.